Selective utilization of SHMT2 alternative promoter by HIF1α and TFE3 resulted in SHMT2 isoform expression shift, which might be implicated in adaptation of ovarian cancer cells under metabolic stress. Here, SHMT2 is linked to ovarian carcinoma.